DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Feldene (Piroxicam) - Adverse Event Reports - Hospitalization - Tongue Discolouration

 



Index of reports > Cases resulting in hospitalization (22) > Cases with Tongue Discolouration (3)

Below is the selection of adverse event reports related to Feldene (Piroxicam) that includes cases resulting in hospitalization where reactions include tongue discolouration.

Adverse event in male receiving Feldene (Piroxicam)

Reported by a physician from Belgium on 2007-06-28

Patient: male, weighing 53.0 kg (116.6 pounds)

Adverse reactions / side effects: Blood Bilirubin Increased, Vomiting, Tongue Discolouration, Blood Lactate Dehydrogenase Increased, Chromaturia, Cholelithiasis, Overdose, Aspartate Aminotransferase Increased, Microlithiasis, Blood Creatinine Increased

Adverse event resulted in: hospitalization

Suspect drug(s):
Benzodiazepine Derivatives

Feldene
    Dosage: text:20-460 mg. tdd

Uropyrine

Other drugs received by patient: Desloratadine



Adverse event in 14 year old male receiving Feldene (Piroxicam)

Reported by a physician from Belgium on 2007-06-01

Patient: 14 year old male, weighing 55.0 kg (121.0 pounds)

Adverse reactions / side effects: Blood Bilirubin Increased, Vomiting, Overdose, Tongue Discolouration, Chromaturia, Blood Creatinine Increased

Adverse event resulted in: hospitalization

Suspect drug(s):
Benzodiazepine Derivatives

Feldene
    Dosage: text:20-460 mg. tdd

Uropyrine

Other drugs received by patient: Desloratadine



Adverse event in 14 year old male receiving Feldene (Piroxicam)

Reported by a physician from Belgium on 2007-05-22

Patient: 14 year old male

Adverse reactions / side effects: Vomiting, Tongue Discolouration, Chromaturia, Blood Creatinine Increased

Adverse event resulted in: hospitalization

Suspect drug(s):
Benzodiazepine Derivatives

Feldene

Uropyrine

Other drugs received by patient: Desloratadine

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009